News
Early intervention with IL-17 inhibitors among patients with plaque psoriasis is associated with improved relapse and remission rates.
“This study suggests that subclinical synovitis is more prevalent among patients with psoriasis without musculoskeletal involvement than healthy controls, suggesting that imaging may help identify ...
A new discovery could change how type 1 diabetes is diagnosed and managed in individuals of African descent, researchers say.
Tildrakizumab is an interleukin-23 antagonist approved under the brand name Ilumya for the treatment of plaque psoriasis.
Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced it ...
Biocon's subsidiary, Biocon Biologics, has introduced Nepexto, a biosimilar to Enbrel (Etanercept), in Australia for treating ...
The drug is indicated for the treatment rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic ...
Etanercept is a TNF (tumor necrosis factor) inhibitor used to treat several autoimmune conditions, including rheumatoid ...
Struggling to relive a dry and itchy scalp? Here are seven scalp care products formulated to soothe the irritation.
Taking care of your skin is important, and just by making sure you have a good skincare routine that works for your skin type ...
Roxy Janceko has taken to social media to share a rare photo with her entire family - including her little seen husband ...
17h
News-Medical.Net on MSNFad diets and supplements fuel new wave of hidden skin problems, study findsA new review explains how fad diets and unregulated supplements promoted online can cause serious skin, hair, and nail ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results